ProShare Advisors’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Sell |
33,557
-1,325
| -4% | -$4.58K | ﹤0.01% | 1851 |
|
|
2025
Q1 | $91.4K | Sell |
34,882
-7,318
| -17% | -$19.2K | ﹤0.01% | 1852 |
|
|
2024
Q4 | $174K | Buy |
42,200
+15,492
| +58% | +$63.8K | ﹤0.01% | 1927 |
|
|
2024
Q3 | $189K | Buy |
26,708
+5,825
| +28% | +$41.2K | ﹤0.01% | 1744 |
|
|
2024
Q2 | $136K | Sell |
20,883
-5,331
| -20% | -$34.8K | ﹤0.01% | 1611 |
|
|
2024
Q1 | $218K | Buy |
26,214
+3,394
| +15% | +$28.2K | ﹤0.01% | 1626 |
|
|
2023
Q4 | $251K | Buy |
22,820
+3,107
| +16% | +$34.2K | ﹤0.01% | 1504 |
|
|
2023
Q3 | $166K | Buy |
19,713
+102
| +0.5% | +$858 | ﹤0.01% | 1524 |
|
|
2023
Q2 | $246K | Buy |
19,611
+1,178
| +6% | +$14.8K | ﹤0.01% | 1411 |
|
|
2023
Q1 | $304K | Sell |
18,433
-2,517
| -12% | -$41.5K | ﹤0.01% | 1207 |
|
|
2022
Q4 | $313K | Buy |
20,950
+3,355
| +19% | +$50.1K | ﹤0.01% | 1215 |
|
|
2022
Q3 | $394K | Buy |
17,595
+538
| +3% | +$12K | ﹤0.01% | 998 |
|
|
2022
Q2 | $286K | Sell |
17,057
-7,270
| -30% | -$122K | ﹤0.01% | 1239 |
|
|
2022
Q1 | $728K | Sell |
24,327
-6,173
| -20% | -$185K | ﹤0.01% | 1064 |
|
|
2021
Q4 | $936K | Buy |
30,500
+3,005
| +11% | +$92.2K | ﹤0.01% | 1058 |
|
|
2021
Q3 | $867K | Sell |
27,495
-4,291
| -13% | -$135K | ﹤0.01% | 952 |
|
|
2021
Q2 | $1.16M | Buy |
31,786
+7,080
| +29% | +$259K | ﹤0.01% | 945 |
|
|
2021
Q1 | $854K | Buy |
24,706
+3,692
| +18% | +$128K | ﹤0.01% | 1088 |
|
|
2020
Q4 | $873K | Buy |
+21,014
| New | +$873K | ﹤0.01% | 948 |
|